Omega Fund Management, LLC
Top Portfolio Positions
10 positions ·
$163,141,764 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
2,392,150 | $47,579,863 | 29.16% | |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
8,081,089 | $34,667,871 | 21.25% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
3,289,661 | $29,442,465 | 18.05% | |
| KMTS |
Kestra Medical Technologies, Ltd.
Healthcare
|
1,022,149 | $20,371,429 | 12.49% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
1,316,183 | $13,188,153 | 8.08% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
876,357 | $5,967,991 | 3.66% | |
| ALMS |
Alumis Inc.
Healthcare
|
241,255 | $5,314,847 | 3.26% | |
| SANA |
Sana Biotechnology, Inc.
Healthcare
|
843,750 | $2,430,000 | 1.49% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
455,361 | $2,276,805 | 1.40% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
248,672 | $1,902,340 | 1.17% |
Portfolio Trend
25 quarters · across all stocks
Holdings in ENGN
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,967,991 | 876,357 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,913,503 | 876,357 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,595,018 | 526,357 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,915,939 | 526,357 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,358,079 | 526,357 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,500,274 | 526,357 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,103,956 | 1,076,357 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,150,046 | 1,076,357 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,244,251 | 1,076,357 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,440,745 | 1,131,175 | Shares | Sole | 2024-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||